Navigation Links
Naviscan Announces a New Chairman and Board Member
Date:2/4/2008

SAN DIEGO, Feb. 4 /PRNewswire/ -- Naviscan PET Systems, a privately held company and the leader in organ-specific molecular imaging, announced today the appointment of Paul J. Mirabella as Chairman of the Board, in addition to retaining his responsibilities as President and CEO, and the addition of Dr. Abhi Acharya to the Board of Directors.

Mr. Mirabella joined Naviscan as President and Chief Executive Officer in July 2007 bringing 32 years of leadership experience in the diagnostic imaging industry. Prior to joining Naviscan, he held the position of President and CEO for the Global Diagnostic Imaging division of GE Healthcare. Throughout his career, he has held global leadership roles in technology development, sales, service, marketing and business management in ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). He has contributed to the evolution of imaging technology and is responsible for the development of 4 patents in the area of Computed Tomography. Mr. Mirabella holds degrees in Aerospace Engineering and Applied Mechanics from Polytechnic Institute of New York, a Masters in Mechanical Engineering from Central Florida University, and is a graduate of the GE Business Program accredited by the University of Wisconsin-Whitewater.

Dr. Acharya has over 30 years experience in the scientific and business aspects of the medical device field. His primary focus is in U.S. and International device laws, regulations and clinical trial strategies. Dr. Acharya has previously held numerous senior-level positions over a 16-year period beginning in 1977 at the U.S. Food and Drug Administration, including Director of the Division of Cardiovascular, Respiratory and Neurological Devices, where he directed the review and approval of PMA, IDE and 510(k) submissions during a period of rapid evolution for device technologies that included the Artificial Heart and Implantable Defibrillators, Rate-responsive Pacemakers, Aneurysm Implants, Laser Catheters, and Coronary Stents. Dr. Acharya holds a B. Tech. Degree in Metallurgical Engineering from the Indian Institute of Technology, Kharagpur, India, and an M.S. and Ph.D. in Biomaterials Engineering from Northwestern University in Chicago, Illinois.

"Naviscan is on the heels of a breakthrough year in breast cancer imaging and we are delighted to have the expertise of an impressive Board and a new commercial and technology team -- it is going to be an incredible year for the company," said Mr. Mirabella, Chairman and CEO.

About Naviscan PET Systems, Inc.

Naviscan PET Systems, founded in 1995, designs and develops compact, high-resolution PET scanners that are intended to provide organ-specific imaging, and guide radiological and surgical procedures. Naviscan has developed the PEM Flex(TM) Solo II, a high resolution PET scanner designed to image small body parts such as the breast. PEM Flex(TM) is utilized in clinical research studies, funded in part by the National Institutes of Health. The Company is headquartered in San Diego, California.

Sherri Antoniak

Corporate Communications

Naviscan PET Systems Inc.

650-740-4810

santoniak@naviscanpet.com

http://www.naviscanpet.com


'/>"/>
SOURCE Naviscan PET Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Naviscans PEM Flex(TM) Scanner Shows Promising New Data in Breast Cancer Management
2. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... Congratulations to Head Over Heels’ elite ... 12th. Ms. Esparza qualified into this prestigious status after winning the Vault, ... Vegas, Nevada. Frida is one of approximately 25 gymnasts in the nation who ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most ... Jensie Gran Fondo of Marin. For the second year in a row, cyclists ... sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to over ...
(Date:2/23/2017)... CO (PRWEB) , ... February 23, 2017 , ... The ... announce the winner of the 2016 National Education Policy Center Bunkum Award. We invite ... reviewed in 2016. , This year’s Bunkum winner is the Center for American Progress ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... first two episodes of WE TV’s “Mama June: From Not to Hot,” which will ... TV notable, “Mama” June Shannon, known to millions from the 2012 reality television series, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - 2016, provides ... research answers the following questions: What are ... they positioned in the Global Menopause market? What are ...
(Date:2/23/2017)... , Feb. 23, 2017 Research and ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... data and benchmarks in the global Fibromyalgia market. The ... the key drugs marketed for Fibromyalgia and their clinical attributes? How ...
(Date:2/23/2017)... 23, 2017 Obese people are ... for varicose veins in their body. The rising number ... the adoption of endovenous laser therapy for treatment of ... laser therapy market, published by Future Market Insights, ... and consequences of obesity have collectively factored the growth ...
Breaking Medicine Technology: